SCHEMBL457744

SCHEMBL457744

Nc1ncc(-c2ccc([N+](=O)[O-])cc2)s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.60
APP P05067 2/20 0.58
MAPT P10636 5/20 0.56
LMNA P02545 2/20 0.56
GAA P10253 3/20 0.55
MGAM O43451 2/20 0.55
SI P14410 2/20 0.55
MGAM2 Q2M2H8 2/20 0.55
CSNK2A1 P68400 1/20 0.55
ALDH1A1 P00352 6/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
PKM P14618 2/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28067065 0.91 XDH (0.56) XDHAPPMAPTLMNAGAA
SCHEMBL27908158 0.80 XDH (0.56) XDHAPPMAPTLMNAGAA
Hydrochloric Acid SCHEMBL158931 0.78 XDH (0.55) XDHAPPMAPTLMNAGAA
SCHEMBL1756208 0.78 XDH (0.57) XDHAPPMAPTLMNAGAA
Hydrochloric Acid SCHEMBL162850 0.77 XDH (0.53) XDHAPPMAPTLMNAGAA
SCHEMBL14541793 0.76 XDH (0.56) XDHAPPMAPTLMNAGAA
SCHEMBL20379759 0.76 XDH (0.76) XDHAPPMAPTLMNAGAA
SCHEMBL12091997 0.76 CSNK2A1 (0.62) APPMAPTGAACSNK2A1ALDH1A1
Hydrochloric Acid SCHEMBL163366 0.76 XDH (0.52) XDHAPPMAPTLMNAGAA
Hydrochloric Acid SCHEMBL28805026 0.75 XDH (0.55) XDHAPPMAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102993117-A Preparation method of 2-amino-5-(4-amino phenyl)-thiazole ZHANGJIAGANG CITY DAWEI ASSISTANTS INSDUSTRY CO LTD 2013-03-27 CN claimed
EP-2615084-B1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS TAIHO PHARMACEUTICAL CO LTD (JP) 2016-01-06 EP disclosed
US-9181183-B2 Prostaglandin D synthase inhibitory piperidine compounds TAIHO PHARMACEUTICAL CO., LTD. (JP) 2015-11-10 US disclosed
CN-103080086-B Prostaglandin D synthase inhibitory piperidine compounds TAIHO PHARMACEUTICAL CO LTD 2014-11-05 CN disclosed
EP-2615084-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS Taiho Pharmaceutical Co., Ltd. (JP) 2013-07-17 EP disclosed
US-20130165438-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2013-06-27 US disclosed
CN-102993117-A Preparation method of 2-amino-5-(4-amino phenyl)-thiazole ZHANGJIAGANG CITY DAWEI ASSISTANTS INSDUSTRY CO LTD 2013-03-27 CN disclosed
CN-102993117-A Preparation method of 2-amino-5-(4-amino phenyl)-thiazole ZHANGJIAGANG CITY DAWEI ASSISTANTS INSDUSTRY CO LTD 2013-03-27 CN disclosed
WO-2012033069-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS 大鵬薬品工業株式会社 (JP) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165438-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS PTGIS, PTGS1, PTGDR XDH 59/4885APP 3109/4885MAPT 4841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.